Insufficient radiofrequency ablation promotes angiogenesis of residual hepatocellular carcinoma via HIF-1α/VEGFA - Wikidata - awgldk - TriplyDB

Insufficient radiofrequency ablation promotes angiogenesis of residual hepatocellular carcinoma via HIF-1α/VEGFA

Insufficient radiofrequency ablation promotes angiogenesis of residual hepatocellular carcinoma via HIF-1α/VEGFA

http://www.wikidata.org/entity/Q28483727

about

Radio-frequency ablation-based studies on VX2rabbit models for HCC treatment.Thermal Ablative Therapies and Immune Checkpoint Modulation: Can Locoregional Approaches Effect a Systemic Response?Incomplete radiofrequency ablation enhances invasiveness and metastasis of residual cancer of hepatocellular carcinoma cell HCCLM3 via activating β-catenin signaling Nanodrug-enhanced radiofrequency tumor ablation: effect of micellar or liposomal carrier on drug delivery and treatment efficacy Overexpression and correlation of HIF-2α, VEGFA and EphA2 in residual hepatocellular carcinoma following high-intensity focused ultrasound treatment: Implications for tumor recurrence and progression Long noncoding RNA expression profiles in sub-lethal heat-treated hepatoma carcinoma cells.Radiofrequency ablation-induced upregulation of hypoxia-inducible factor-1α can be suppressed with adjuvant bortezomib or liposomal chemotherapy.MicroRNA-26a inhibits angiogenesis by down-regulating VEGFA through the PIK3C2α/Akt/HIF-1α pathway in hepatocellular carcinoma.HIF-1α and HIF-2α: siblings in promoting angiogenesis of residual hepatocellular carcinoma after high-intensity focused ultrasound ablation.The relationship between endothelial progenitor cell populations and epicardial and microvascular coronary disease-a cellular, angiographic and physiologic study.Radiofrequency ablation for single hepatocellular carcinoma 3 cm or less as first-line treatment.Systemic siRNA Nanoparticle-Based Drugs Combined with Radiofrequency Ablation for Cancer Therapy.Sorafenib suppresses the epithelial-mesenchymal transition of hepatocellular carcinoma cells after insufficient radiofrequency ablation.Radiofrequency ablation-combined multimodel therapies for hepatocellular carcinoma: Current status.After insufficient radiofrequency ablation, tumor-associated endothelial cells exhibit enhanced angiogenesis and promote invasiveness of residual hepatocellular carcinoma Hepatic Radiofrequency Ablation-induced Stimulation of Distant Tumor Growth Is Suppressed by c-Met Inhibition.Elevated MTSS1 expression associated with metastasis and poor prognosis of residual hepatitis B-related hepatocellular carcinoma.Insufficient radiofrequency ablation promotes the growth of non-small cell lung cancer cells through PI3K/Akt/HIF-1α signals.Incomplete radiofrequency ablation accelerates proliferation and angiogenesis of residual lung carcinomas via HSP70/HIF-1α.Radiofrequency ablation of hepatocellular carcinoma sized > 3 and ≤ 5 cm: is ablative margin of more than 1 cm justified?Insufficient radiofrequency ablation promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells through Akt and ERK signaling pathways.YC-1 enhances the anti-tumor activity of sorafenib through inhibition of signal transducer and activator of transcription 3 (STAT3) in hepatocellular carcinoma.Molecular targeting agents associated with transarterial chemoembolization or radiofrequency ablation in hepatocarcinoma treatment.Modulation of hypoxia-signaling pathways by extracellular linc-RoR.Clinical characteristics and prognostic factors for advanced hepatocellular carcinoma with extrahepatic metastasis.Various complications of percutaneous radiofrequency ablation for hepatic tumors: radiologic findings and technical tips.The future of biology in driving the field of hyperthermia.Pathophysiology of recurrent hepatocellular carcinoma after radiofrequency ablation.Endothelial lineage differentiation from induced pluripotent stem cells is regulated by microRNA-21 and transforming growth factor β2 (TGF-β2) pathways.Inflammation and cancer: inhibiting the progression of residual hepatic VX2 carcinoma by anti-inflammatory drug after incomplete radiofrequency ablation.Increased matrix stiffness promotes tumor progression of residual hepatocellular carcinoma after insufficient heat treatment.Insufficient radiofrequency ablation promotes human hepatoma SMMC7721 cell proliferation by stimulating vascular endothelial growth factor overexpression.Effect of a hypoxic microenvironment after radiofrequency ablation on residual hepatocellular cell migration and invasion.Surgical and Pathological Changes after Radiofrequency Ablation of Thyroid Nodules.Clinicopathology of recurrent hepatocellular carcinomas after radiofrequency ablation treated with salvage surgery.Sublethal heat treatment promotes epithelial-mesenchymal transition and enhances the malignant potential of hepatocellular carcinoma.Expressions of hypoxia-inducible factor-1 and epithelial cell adhesion molecule are linked with aggressive local recurrence of hepatocellular carcinoma after radiofrequency ablation therapy.Targeting STAT3 to Suppress Systemic Pro-Oncogenic Effects from Hepatic Radiofrequency Ablation.[Change of ERCC1 expression of residual VX2 squamous carcinoma cells in rabbit lung after radiofrequency ablation].Salvage treatment for local recurrence of hepatocellular carcinoma after local ablation therapy.

P2860

Q26741499-9C545FFC-A7EE-4D0E-A24D-DB0E92BEABD2 Q26751230-3718ABC0-888E-4DFF-B64C-5F1261E4E79B Q27318569-1DA37F74-C7B8-4107-89C7-E42CA38699AC Q28542027-74FC7C44-D62D-4C1A-BE25-F415F06AEB95 Q33744888-ECDC1527-D35B-47D8-AA9F-4BBDA1F2CF04 Q33922769-6DDBBE1E-AF76-493A-B826-2C0E0F3CB123 Q34725980-4FF8E8EB-0D5B-4B49-AF19-6871CCC76380 Q35032496-B1B9282C-A60E-4148-A6A3-279D59CA5FC3 Q35097628-36085FC8-2DA1-42DB-A149-D09C51196DBE Q35148886-73305394-CE04-4689-A7DF-3DD64F08AC3E Q35567648-B4AA31A2-3008-4ACD-A794-915FE3E20205 Q35831738-7B4A3875-C1C8-4D3B-A7FA-2B853FE4F1D8 Q35856250-BFD8F015-A779-46B1-93BC-3DA0B4E19A0C Q36390438-AA166E67-7B59-4CC1-99FC-C845DAF925D7 Q36527253-90674DA0-C013-4C8E-8194-6BC01AC9D9CD Q36762751-EDE2E0C6-1F0F-4394-A04A-79C60C1CD966 Q36937807-D8ADC91A-5948-4605-A39B-D2EED8C4F58C Q36949594-02A0F1B5-E331-4385-8F16-B08349581CB3 Q37066692-32845582-2289-4ED7-A743-078A8BC67BB8 Q37317451-93BDB3AB-14A2-4CBE-A00A-B028E83A0869 Q37348249-F8A36CE1-EE60-421B-AC49-4EC2A79A5F3F Q37493227-7C7AE673-62BF-4E57-9622-0EA34010586E Q37581359-E9008099-4F19-4248-A1A8-E5EA284DE590 Q37674697-A0F65202-76E2-4513-8775-C3DD7834AE37 Q37722175-84E72D6C-5747-4591-9918-C722BB7DFE0C Q38166333-0D84E638-F197-4C36-A5CC-47E057CF9BBA Q38724564-460AEF81-A0A3-4F03-B9CA-DA0A72587FC4 Q38779808-740FF68D-2B56-4E3F-8B9D-92AD60612448 Q39041655-D5B99D50-F5F8-478A-82D2-A4563A5C3EE8 Q40044969-354B93C0-B71A-43B4-8C5C-60180BDE48C6 Q41595426-87CE011D-AB53-4478-B26D-DA71E79F14E3 Q42025842-7C16BED0-BB6C-4558-B84E-5DD4E677900B Q42098752-5DB415A9-3E73-4428-A79A-42D09FC35A1F Q42413389-1E842C05-C071-44A0-A868-10E49B44116E Q44379007-22873D4D-F4BC-4AE7-9371-C8AEB244545B Q44536329-7373CA55-F1B4-4853-9E42-AD40793F8B65 Q44670065-BB555FD4-DF5F-4F48-B0F0-EBB43735B610 Q45871652-95B7693D-474E-43CB-83F8-AF41C637BA1D Q46293669-27B2EF53-FAD3-4866-A508-9E28AE4D9FC4 Q50478924-DE0A9C2E-8367-45CB-8C21-566C0CD99D40

P2860

Insufficient radiofrequency ablation promotes angiogenesis of residual hepatocellular carcinoma via HIF-1α/VEGFA

http://www.wikidata.org/entity/Q28483727

description

2012 nî lūn-bûn

@nan

2012 թուականին հրատարակուած գիտական յօդուած

@hyw

2012 թվականին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Insufficient radiofrequency ab ...... lar carcinoma via HIF-1α/VEGFA

@ast

Insufficient radiofrequency ab ...... lar carcinoma via HIF-1α/VEGFA

@en

Insufficient radiofrequency ab ...... lar carcinoma via HIF-1α/VEGFA

@nl

type

label

Insufficient radiofrequency ab ...... lar carcinoma via HIF-1α/VEGFA

@ast

Insufficient radiofrequency ab ...... lar carcinoma via HIF-1α/VEGFA

@en

Insufficient radiofrequency ab ...... lar carcinoma via HIF-1α/VEGFA

@nl

prefLabel

Insufficient radiofrequency ab ...... lar carcinoma via HIF-1α/VEGFA

@ast

Insufficient radiofrequency ab ...... lar carcinoma via HIF-1α/VEGFA

@en

Insufficient radiofrequency ab ...... lar carcinoma via HIF-1α/VEGFA

@nl

P1433

Q28483727-09C0C750-952B-443B-9305-70230D5644BD

P1476

Q28483727-99498371-AAD8-41F8-A5C2-9A52B67589B9

P2093

Q28483727-36257CB2-86E0-4181-B66D-677BFD69CBEA

Q28483727-364B1EEA-89D7-4CDE-AA00-40E649D18757

Q28483727-4FA8AFA6-375B-423A-B3D4-012304762E27

Q28483727-56686383-8E98-4B5C-8070-C9496BF23FC8

Q28483727-82C8FD4B-89B4-44F5-8172-C21AFD06AE8A

Q28483727-900DECA8-BF8E-4EE0-9C76-68F546C152D4

Q28483727-974A48D7-D267-4F3B-910C-A730D8CD4A92

Q28483727-D811F57F-6DD0-4A31-8622-AF373E430BDB

Q28483727-DD76EB6B-DE3F-475D-B1F1-7607F43615C3

P2860

Q28483727-046DBF68-5B97-43AE-A821-CC2D582D1100

Q28483727-13CC44E2-9725-4BEE-A7CB-382F0B0BB7A1

Q28483727-19590991-0973-497F-9ABE-C94EBEDB973E

Q28483727-209481E3-FE7C-447C-93B2-E4EB99A90276

Q28483727-227CBF16-20FB-491D-8E29-D63B6514108F

Q28483727-2BC23E6F-B327-405C-B005-D6817C7475FE

Q28483727-2F1A2979-5391-4EF7-9A3D-F28A7432ED46

Q28483727-39221876-E745-4B72-BEFB-D59D16E09185

Q28483727-3A7C078C-3731-46A5-919D-B9D0F89DB070

Q28483727-3DDDABC6-DC98-44D6-BE6D-3A07DF9B2FDF

P304

Q28483727-54468239-5192-4371-9C39-C1658632FCE1

P31

Q28483727-D616802C-53BB-4B20-9E72-1FFDFD7C1611

P3181

Q28483727-8E53E742-409B-44BE-BC3A-DE529B3BF013

P356

Q28483727-E42CA964-D69D-4E16-9690-74EA16781CAD

P407

Q28483727-28452913-6433-4C65-8A37-BFD42EF8F085

P433

Q28483727-D624E508-A44C-43EA-AEEC-28B52F611039

P478

Q28483727-0B98251A-61A5-40AC-878F-09E9FC0CC2BE

P577

Q28483727-18AAC4CB-DDB2-40D4-BFC5-99E045E6E415

P5875

Q28483727-61BB5535-EE0B-4B1C-95C3-39BEB496B715

P698

Q28483727-00ECE7B1-671B-48CF-89FF-20A943232084

P932

Q28483727-8C0BF9F1-043D-46E7-8F14-EFAB33CDC58E

P3181

P356

JOURNAL.PONE.0037266

P1433

P1476

Insufficient radiofrequency ab ...... lar carcinoma via HIF-1α/VEGFA

@en

P2093

Aimin Zhou

http://www.w3.org/2001/XMLSchema#string

Bing Pan

http://www.w3.org/2001/XMLSchema#string

Jian Kong

http://www.w3.org/2001/XMLSchema#string

Jinge Kong

http://www.w3.org/2001/XMLSchema#string

Lemin Zheng

http://www.w3.org/2001/XMLSchema#string

Shan Ke

http://www.w3.org/2001/XMLSchema#string

Shuying Dong

http://www.w3.org/2001/XMLSchema#string

Wen-bing Sun

http://www.w3.org/2001/XMLSchema#string

Xiuli Li

http://www.w3.org/2001/XMLSchema#string

P2860

Ubiquitin-specific protease 19 (USP19) regulates hypoxia-inducible factor 1α (HIF-1α) during hypoxia

Targeting HIF-1 for cancer therapy

Expression of hypoxia-inducible factor 1alpha in brain tumors: association with angiogenesis, invasion, and progression

Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

Expression of hypoxia-inducible factor 1? in brain tumors

Hypoxia--a key regulatory factor in tumour growth

Tumor angiogenesis

Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor

Mechanisms of angiogenesis and arteriogenesis

P304

e37266

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1005134

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PONE.0037266

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225030201

http://www.w3.org/2001/XMLSchema#string

P698

22615958

http://www.w3.org/2001/XMLSchema#string

P932

3352883

http://www.w3.org/2001/XMLSchema#string